Simbol PTGX | |
Simbol | PTGX |
Simbol eToro | PTGX |
MarketWatch | PTGX |
Finviz | PTGX |
Yahoo Finance | PTGX |
Google Finance | PTGX |
TradingView | PTGX |
Investing.com | PTGX |
Denumire | Protagonist Therapeutics Inc. |
Website | protagonist-inc.com |
Piața | NASDAQ |
ISIN | US74366E1029 |
Sector | Health Technology |
Industrie | Biotechnology |
Monedă | USD |
Preț | 27,6100 USD |
Capitalizare bursieră | 1,580 mld. USD |
P/E | -9,74 |
Beta | 1,7838 |
EPS | -2,8336 |
Profit anual | +203,89% |
Dată actualizare | 23.06.2023 |
Descriere |
Protagonist Therapeutics, Inc. a clinical-stage biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address unmet medical needs. Its product pipeline include PTG-300, PTG-200, and PN-943 The company was founded by Mark L. Smythe on August 22, 2006 and is headquartered in Newark, CA. |
Data | P/E | Beta | Capitalizare | Dividend | EPS | Profit anual | Preț |
08.12.2021 | 0,00 | 1,2271 | 1,610 | 0,00% | -2,4114 | +37,99% | $33,82 |
23.06.2023 | -9,74 | 1,7838 | 1,580 | 0,00% | -2,8336 | +203,89% | $27,61 |